Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,351 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $562.67 | 13 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $182.23 | 3 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $142.78 | 4 | $0 (2021) |
| PORTOLA PHARMACEUTICALS, INC. | $130.81 | 1 | $0 (2019) |
| La Jolla Pharmaceutical Company | $121.69 | 2 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $108.23 | 1 | $0 (2021) |
| PFIZER INC. | $64.68 | 2 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $37.55 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $220.37 | 2 | AstraZeneca Pharmaceuticals LP ($220.37) |
| 2021 | $306.06 | 8 | AstraZeneca Pharmaceuticals LP ($156.48) |
| 2020 | $273.71 | 11 | La Jolla Pharmaceutical Company ($78.56) |
| 2019 | $550.50 | 7 | PORTOLA PHARMACEUTICALS, INC. ($130.81) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/14/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $112.18 | General |
| Category: Rare Disease | ||||||
| 03/10/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $108.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/17/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Gastroenterology | ||||||
| 10/06/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Gastroenterology | ||||||
| 08/12/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/22/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/08/2021 | Alexion Pharmaceuticals, Inc. | Andexxa (Drug) | Food and Beverage | In-kind items and services | $108.23 | General |
| Category: Hematology | ||||||
| 05/13/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $118.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/27/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/20/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/13/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.49 | General |
| Category: Cardiovascular | ||||||
| 12/10/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/05/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/10/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/05/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/15/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/24/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/13/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $52.06 | General |
| Category: Cardiovascular | ||||||
| 02/03/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/09/2020 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $78.56 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 11/14/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $102.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/02/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $105.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/08/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $47.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 780 | 832 | $866,457 | $75,344 |
| 2022 | 4 | 607 | 635 | $567,491 | $52,860 |
| 2021 | 5 | 241 | 248 | $252,332 | $21,208 |
| 2020 | 3 | 195 | 199 | $259,894 | $21,491 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 391 | 422 | $630,872 | $55,062 | 8.7% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 163 | 172 | $172,502 | $14,962 | 8.7% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 43 | 46 | $30,317 | $2,468 | 8.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 11 | 11 | $20,251 | $1,773 | 8.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 172 | 181 | $12,515 | $1,079 | 8.6% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 265 | 281 | $409,380 | $37,963 | 9.3% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 120 | 124 | $120,881 | $11,596 | 9.6% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 38 | 38 | $24,309 | $2,102 | 8.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 184 | 192 | $12,921 | $1,198 | 9.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 98 | 98 | $168,204 | $13,350 | 7.9% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 49 | 50 | $53,065 | $4,735 | 8.9% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 43 | 46 | $25,281 | $2,377 | 9.4% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2021 | 17 | 17 | $3,642 | $532.80 | 14.6% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 34 | 37 | $2,140 | $212.52 | 9.9% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 108 | 111 | $188,713 | $15,556 | 8.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 51 | 52 | $51,067 | $4,606 | 9.0% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 36 | 36 | $20,114 | $1,329 | 6.6% |
About Dr. Joshua Chang, DO
Dr. Joshua Chang, DO is a Emergency Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2018. The National Provider Identifier (NPI) number assigned to this provider is 1699272906.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Chang, DO has received a total of $1,351 in payments from pharmaceutical and medical device companies, with $220.37 received in 2022. These payments were reported across 28 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,351).
As a Medicare-enrolled provider, Chang has provided services to 1,823 Medicare beneficiaries, totaling 1,914 services with total Medicare billing of $170,903. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Oklahoma City, OK
- Active Since 04/12/2018
- Last Updated 08/20/2025
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1699272906
Products in Payments
- LOKELMA (Drug) $450.49
- ELIQUIS (Drug) $246.91
- ANDEXXA (Biological) $242.99
- RELISTOR (Drug) $142.78
- GIAPREZA (Drug) $121.69
- Andexxa (Drug) $108.23
- XARELTO (Drug) $37.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Oklahoma City
Alexander Frank, M.d, M.D
Emergency Medicine — Payments: $3.1M
Mohammad Razaq, M.d, M.D
Emergency Medicine — Payments: $177,813
Jose Borrego Acosta, Md, MD
Emergency Medicine — Payments: $76,213
Lindsey Epperson
Emergency Medicine — Payments: $36,931
Dr. Tyson Quy, M.d, M.D
Emergency Medicine — Payments: $35,983
Michael Partin, M.d, M.D
Emergency Medicine — Payments: $10,117